Furthermore, according to available evidence, inflammatory factors such as interleukin (IL)‐1β, IL‐6, and tumor necrosis factor (TNF)‐α levels have also been shown to rise in patients with migraine, especially during migraine attack phases (Fidan et al., 2006; Martami et al., 2018). Here, IL1B is linked to migraine disorder.